
Strive Health Secures $550M to Advance Value-Based Kidney Care Model
Strive Health's Series D funding was led by New Enterprise Associates, and included participation from CVS Health Ventures, CapitalG, Echo Health and several others.
Strive Health's Series D funding was led by New Enterprise Associates, and included participation from CVS Health Ventures, CapitalG, Echo Health and several others.
Hello Patient's Series A round was led by Scale Venture Partners and included participation from 8VC, Bling Capital, Max Ventures, Remus Capital and FirstLook Partners.
Sleep.ai’s $5.5 million in funding was led by Treasure Coast Ventures and included participation from Nurture Ventures, the Harvard Business School Alumni Angels of Greater New York and Supermoon Capital.
Develop Health's Series A funding round was led by Wing Venture Capital, and included participation from Afore Capital, J Ventures and South Park Commons.
Arbital Health’s $31 million Series B round was led by Valtruis and included participation from existing investors Transformation Capital, Shaper Capital and Healthy Ventures.
Certify's $40 million round was led by Transformation Capital, and included support from General Catalyst, Upfront Ventures and SemperVirens.
WellTheory's $5 million raise included support from new investors Samsung Next, Opal Ventures and Up2 Fund, as well as existing investors Accel, OVO Fund and BoxGroup.
As the safety-net landscape shifts and funding uncertainty grows, the path forward is clear. By investing in highly coordinated, data-informed care and aligning health plans, providers and communities around shared goals, we can build a system that reaches individuals with complex care needs, supports whole-person health initiatives and strengthens care across the board.
A webinar scheduled for Thursday May 8 at 1 pm ET sponsored by Mercury will explore how early-stage medtech and biopharma investors are looking at the market and how they're advising startups in the wake of cuts to NIH and SBIR grants.
GEM HEALTH's Series A round was co-led by HealthTrend Capital and LFE Capital and included participation from existing investors Base10 Partners and Mairs & Power Venture Capital.
This year, venture capitalists in the digital health landscape have many more quality investment opportunities than they did in the past couple years, according to Oak HC/FT Partner Billy Deitch. He noted that many startups have been preserving the capital over the past two years with the plan to raise funds in 2025.
If you rely on federal grants as your sole means of support, you’re tying your destiny to forces outside your control. There are other roads to success in health and medical research. By pursuing them, you might gain more freedom, fewer administrative hurdles, and the chance to save lives faster.
Fay's $50 million Series B round was led by Goldman Sachs. In total, the company has raised $75 million.
Hone Health's Series A round included participation from Tribe Capital, PIF, Republic Capital, Vibe VC, Humbition, Hanwha, Gaingels, Looking Glass Capital, FJ Labs and Agent Capital. In total, the company has raised $39 million.
As President Trump would have most certainly learned on his first day at Wharton, you really have to spend money to make money. If you want to make America truly a world leader, why on earth would you stifle the institution that contributed an estimated $92.89 billion to the US economy in 2023 alone and has produced over 170 Nobel Laureates since its inception?